Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Palladone approved for pain relief

The Food and Drug Administration (FDA) has approved Palladone (hydromorphone hydrochloride) capsules for the management of persistent moderate to severe pain in patients requiring continuous around-the-clock opioid pain relief for an extended period of time.

26 Sep 2004

Study on the long-term health effects associated with silicone breast implants

It is estimated that between 1.5 million and 2 million women in this country have had breast implants since they first appeared on the market in 1962.

23 Sep 2004

Study into asbestos-related disease shows need for community involvement

Conducted by researchers from the Centre for the Study of Health and Society at the University of Melbourne, the study was spurred by observation that the voices and perspectives of those most affected by asbestos disease are rarely heard in the formulation of responses to Australia’s on-going asbestos disease epidemic.

22 Sep 2004

Stem cell science and orthopedic surgery may reduce failure rate in hip replacements

By combining stem cell science with orthopedic surgery, a team of researchers at the University of British Columbia and Vancouver Coastal Health Research Institute aims to reduce the 10 per cent failure rate in hip replacements and make repeat replacements and other joint repairs obsolete within 10-15 years.

16 Sep 2004

Researchers find way to clean up the drugs market

Researchers from the University of Cambridge and the Massachusetts Institute of Technology have made a breakthrough by using supercritical carbon dioxide (scCO2) as a reaction medium for the preparation of molecules of interest to the pharmaceutical industry.

13 Sep 2004

Hospitals should use latex medical gloves with lower protein and powder levels to reduce latex sensitivity rather than synthetic alternatives

The non-profit, independent evaluator of medical devices notes that while some synthetic alternatives may cost less, latex gloves are still the most cost-effective choice when a glove offering a good level of protection is required.

8 Sep 2004

MorphoSys obtains license on human cell line technology for use in its antibody research

MorphoSys has announced today a non-exclusive license agreement with Dutch biotechnology company Crucell and DSM Biologics.

8 Sep 2004

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Sinovac Biotech Ltd. has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with two doses of either SARS vaccine or placebo.

7 Sep 2004

New drug application for exenatide has been accepted for review

Amylin Pharmaceuticals and Eli Lilly today announced that the New Drug Application for exenatide has been accepted for review by the Food and Drug Administration.

2 Sep 2004

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems

31 Aug 2004

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

At the opening ceremony of the Lausanne, Switzerland, AIDS VACCINE '04 conference, leaders in the field of AIDS vaccine research called for increased political and financial commitment to facilitate the development of preventive and therapeutic AIDS vaccines as a public health imperative in fighting HIV/AIDS.

30 Aug 2004

High tech implants to aid facial reconstruction

Loughborough University researchers have been awarded more than £200,000 to develop state-of-the-art tailor made implants for people requiring facial reconstructive surgery.

27 Aug 2004

Chiron delays Fluvirin influenza virus vaccine shipments

Chiron has announced that, in conducting final internal release procedures for its Fluvirin(R) influenza virus vaccine, the company's quality systems have identified a small number of lots that do not meet product sterility specifications.

26 Aug 2004

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

Contract for the production of an investigational vaccine based on an H9N2 strain of avian influenza virus

In 1999 and 2003, an H9N2 influenza strain caused illness in three people in Hong Kong. Scientists are concerned about H9N2 and other emerging types of avian influenza viruses because as they spread—most commonly through poultry—they continually mutate, increasing chances that they may infect humans, evade the body’s immune response and become more lethal.

17 Aug 2004

Study on RNAi technology targeting neurodegenerative diseases

Sirna Therapeutics has announced the publication of preclinical studies evaluating RNA interference-based therapies for a class of inherited neurodegenerative diseases of the central nervous system (CNS) in the current issue of Nature Medicine.

16 Aug 2004

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

The market for disposable surgical drapes and gowns in Europe has seen steady growth in the recent past owing to the high standards of infection control enforced by the new European Union Medical Device Directive (MDD) and EU regulations.

11 Aug 2004

Genentech announces FDA approval of Avastin manufacturing

Genentech has announced that the U.S. Food and Drug Administration approved the supplemental Biologics License Application (sBLA) for the manufacturing of Avastin™ (bevacizumab) bulk drug substance at the company's facility in Vacaville, California.

11 Aug 2004

FDA asks Utah Medical Products to stop manufacturing and distributing medical devices

The U.S. Food and Drug Administration has announced that it is asking Utah Medical Products, to stop manufacturing and distributing medical devices until the firm has demonstrated that it has corrected deviations from Current Good Manufacturing Practice, as set forth in the Quality System regulation.

11 Aug 2004

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Poised on the brink of phenomenal growth, the oligonucleotides market offers a plethora of opportunities to the enterprising investor. Recent analysis by Frost & Sullivan estimates that the total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010.

9 Aug 2004

Manufacturing News and Research

Further Reading

Palladone approved for pain relief

Study on the long-term health effects associated with silicone breast implants

Study into asbestos-related disease shows need for community involvement

Stem cell science and orthopedic surgery may reduce failure rate in hip replacements

Researchers find way to clean up the drugs market

Hospitals should use latex medical gloves with lower protein and powder levels to reduce latex sensitivity rather than synthetic alternatives

MorphoSys obtains license on human cell line technology for use in its antibody research

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

New drug application for exenatide has been accepted for review

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

High tech implants to aid facial reconstruction

Chiron delays Fluvirin influenza virus vaccine shipments

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Contract for the production of an investigational vaccine based on an H9N2 strain of avian influenza virus

Study on RNAi technology targeting neurodegenerative diseases

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

Genentech announces FDA approval of Avastin manufacturing

FDA asks Utah Medical Products to stop manufacturing and distributing medical devices

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News